Position in ZTS
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$48,146
-$2,684 QoQ
Shares Held
670
+55.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#193
of 265 holders
Holding Since
Dec 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Byrne Asset Management LLC holds $63,053 across 2 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (76.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
670 | $48,146 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
440 | $14,907 |
All Filings in ZTS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,146 | 670 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $50,830 | 430 | Shares | Sole | 2026-04-02 | |
| 2025-12-31 | $49,069 | 390 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $57,064 | 390 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $46,785 | 300 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $69,976 | 425 | Shares | Sole | 2025-04-16 | |
| 2023-12-31 | $5,131 | 26 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $5,219 | 30 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $5,166 | 30 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $6,657 | 40 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $5,862 | 40 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $5,931 | 40 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $6,875 | 40 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $7,543 | 40 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $9,761 | 40 | Shares | Sole | 2022-02-22 | |
| No filing history on record for this holder in this stock. | ||||||